681807-59-0

Basic information

• Product Name: 1-BOC-AMINO-2-VINYLCYCLOPROPANECARBOXYLIC ACID ETHYL ESTER
• Synonyms: Ethyl 1-(tert-butoxycarbonylamino)-2-vinylcyclopropanecarboxylate;Ethyl 1-(tert-butoxycarbonyla;Ethyl 2-[(tert-butoxycarbonyl)aMino]-3-vinylcyclopropanecarboxylate;1-tert-ButoxycarbonylaMino-2-vinyl-cyclopropanecarboxylic acid Methyl ester;ethyl1-((tert-butoxycarbonyl)amino)-2-vinylcyclopropane-1-carboxylate;1-BOC-AMINO-2-VINYLCYCLOPROPANECARBOXYLIC ACID ETHYL ESTER;1-TERT-BUTOXYCARBONYLAMINO-2-VINYL-CYCLOPROPANECARBOXYLIC ACID ETHYL ESTER;Cyclopropanecarboxylic acid, 1-[[(1,1-dimethylethoxy)carbonyl]amino]-2-ethenyl-, ethyl ester
• CAS NO: 681807-59-0
• Molecular Formula: C₁₃H₂₁NO₄
• Molecular Weight: 255.31
• Product Categories: Amino Acid Derivatives
• Mol File: 681807-59-0.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 333.055 °C at 760 mmHg
• Flash Point: 155.226 °C
• Appearance: /
• Density: 1.081 g/cm³
• Vapor Pressure: 0.00019mmHg at 25°C
• Refractive Index: 1.483
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1-BOC-AMINO-2-VINYLCYCLOPROPANECARBOXYLIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 1-BOC-AMINO-2-VINYLCYCLOPROPANECARBOXYLIC ACID ETHYL ESTER(681807-59-0)
• EPA Substance Registry System: 1-BOC-AMINO-2-VINYLCYCLOPROPANECARBOXYLIC ACID ETHYL ESTER(681807-59-0)

Safety Data

• Hazardous Substances Data: 681807-59-0(Hazardous Substances Data)

Usage

General Description

1-BOC-AMINO-2-VINYLCYCLOPROPANECARBOXYLIC ACID ETHYL ESTER is a chemical compound with the molecular formula C13H21NO4. It is an ethyl ester derivative of BOC-protected amino acid and contains a vinylcyclopropane functionality. 1-BOC-AMINO-2-VINYLCYCLOPROPANECARBOXYLIC ACID ETHYL ESTER is often used in the synthesis of peptide-based drugs and other pharmaceutical products. It is also utilized as a building block in organic synthesis and as a reagent in chemical reactions. Its unique structure and properties make it a valuable tool in the field of medicinal and organic chemistry.

InChI:InChI=1/C13H21NO4/c1-6-9-8-13(9,10(15)17-7-2)14-11(16)18-12(3,4)5/h6,9H,1,7-8H2,2-5H3,(H,14,16)

Upstream product

• 681807-60-3 (1R,2S)-ethyl 1-amino-2-vinylcyclopropanecarboxylate hydrochloride 
• 24424-99-5 di-tert-butyl dicarbonate 
• 787548-29-2 (1R,2S)/(1S,2R) 1-amino-2-vinylcyclopropane carboxylic acid ethyl ester 
• 141-78-6 ethyl acetate 
• 1393095-18-5 (E)-ethyl 1-(benzylideneamino)-2-vinylcyclopropanecarboxylate 
• 821-06-7 (E)-1,4-dibromobutene 
• 40682-54-0 ethyl N-benzylideneglycinate 
• 1023795-84-7 C₂₁H₂₁NO₂ 

Downstream Products

• 259214-55-6 (1S,2R)-1-tert-butoxycarbonylamino-2-vinylcyclopropanecarboxylic acid 
• 259217-95-3 N-Boc-(1R,2S)-1-amino-2-vinylcyclopropane carboxylic acid ethyl ester 
• 681807-60-3 (1R,2S)-ethyl 1-amino-2-vinylcyclopropanecarboxylate hydrochloride 
• 259214-54-5 ethyl (1R,2S)-1-amino-2-vinylcyclopropanecarboxylate hydrochloride 
• 259214-54-5 ethyl (1S,2R)-1-amino-2-vinylcyclopropanecarboxylate hydrochloride 
• 923591-34-8 tert-butyl ((1R,2R)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-ethylcyclopropyl)carbamate 
• 159622-10-3 (1R,2S)-1-(tert-butoxycarbonylamino)-2-vinylcyclopropanecarboxylic acid 
• 630421-48-6 tert-butyl ((1R,2S)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)carbamate 
• 924307-75-5 (1S,2R)-ethyl 2-vinyl-1-(tert-butoxycarbonylamino)cyclopropanecarboxylate 
• 746657-36-3 (1R,2S)-ethyl 1-amino-2-vinylcyclopropanecarboxylate 
• 630421-49-7 (1R,2S)-1-amino-N-(cyclopropylsulfonyl)-2-vinylcyclopropanecarboxamide hydrochloride 
• 772337-53-8 (1R,2S)-1-amino-N-(cyclopropylsulfonyl)-2-vinylcyclopropane-1-carboxamide 
• 862119-82-2 (2S,4R)-tert-butyl 2-((1R,2S)-1-(ethoxycarbonyl)-2-vinylcyclopropylcarbamoyl)-4-hydroxypyrrolidine-1-carboxylate 
• 790305-05-4 tert-butyl (2R,6S,13aS,14aR,16aS,Z)-14a-(cyclopropylsulfonylcarbamoyl)-2-hydroxy-5,16-dioxo-1,2,3,5,6,7,8, 9,10,11,13a,14,14a,15,16,16a-hexadecahydronaphthylcyclopropanoyl[e]pyrrolo[1,2-a][1,4]diazacyclopenta decyne-6-yl-carbamate 

Relevant articles and documents

CALPAIN MODULATORS AND METHODS OF PRODUCTION AND USE THEREOF

The present technology relates to compounds, kits, compositions, and methods useful for the treatment of fibrotic disease. In some aspects, the present technology provides for treatment of various diseases or disorders associated or mediated, at least in part, by calpains, such as CAPN1, CAPN2, and/or CAPN9. The present technology is generally applicable to compounds which inhibit myofibroblast differentiation.

Macrocyclic compounds for suppressing replication of hepatitis C virus

A compound as represented by Formula (I) is provided, wherein groups are defined in the description. The compound is used as HCV protease inhibitor for treating HCV infection.

Hepatitis C Virus Inhibitors

Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.